Lactulose Genericon

Quick links to important sections

Lactulose Genericon

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lactulose Genericon

Quick Facts

Property Description
Active ingredient Lactulose (INN)
Form Oral solution (Syrup-like)
Pharmacological class Osmotic laxative / Prebiotic
Common use Relief of constipation
Origin Synthetic disaccharide

What Type of Medicine is Lactulose Genericon?

Lactulose Genericon is a medicinal product containing the single active ingredient, Lactulose. It is classified primarily as an osmotic laxative, a distinction confirming that its method of action is gentle and physical rather than chemically stimulating, which is an important consideration for patient comfort. Lactulose acts as an osmotic agent that is minimally absorbed, passing largely unchanged into the large intestine. This product, manufactured by Genericon Pharma, is typically available as an oral solution and is clinically recognized for its use in managing instances of occasional constipation.


Composition and Mechanism of Action

Lactulose is a synthetic disaccharide molecule, artificially produced from the simple sugars galactose and fructose, ensuring its non-digestible nature. This unique composition is integral to its function. The primary mechanism involves the increase of water content in the stool, alongside a beneficial effect on the gut microbiota. This dual action—physical hydration and microbial support—ensures the relief from constipation is achieved through enhanced stool moisture and support of balanced colonic function. Because the medication is administered as an oral solution, its oral route is effective in delivering the non-systemic treatment directly to the lower gastrointestinal tract.

Regulatory References

  1. NIH Lactulose Drug Information
  2. MedlinePlus

What side effects are possible with Lactulose Genericon?

Possible Side Effects and Safety Information

The official safety profile of lactulose is primarily defined by effects on the gastrointestinal system, as documented in regulatory sources such as the Summary of Product Characteristics (SmPC) and FDA labeling. The adverse reactions are classified by their regulatory frequency.

Frequency-Classified Adverse Reactions

Adverse reactions that have been documented in regulatory sources include those in the Gastrointestinal disorders, Immune system disorders, Investigations, and Skin and subcutaneous tissue disorders system-organ classes.

Classification Adverse Reaction
Common Flatulence, Abdominal pain, Nausea, Vomiting
Uncommon Electrolyte imbalance (resulting from diarrhoea)
Not Known Hypersensitivity reactions (including rash, pruritus, urticaria)

Time- and Dose-Related Safety Patterns

Flatulence may occur during the first few days of treatment but typically resolves thereafter. Diarrhoea and the resulting potential for Electrolyte imbalance (e.g., hypokalemia) are recognized safety concerns associated with the chronic use of high or unadjusted doses, particularly during treatment for hepatic encephalopathy.

Population-Specific Constraints

Use is contraindicated in patients with Galactosaemia or conditions such as gastrointestinal obstruction or the risk of perforation. Regulatory guidance states that the use of laxatives in the pediatric population should be exceptional and medically supervised. For elderly patients or those in bad general condition on therapy lasting longer than six months, periodic control of electrolytes is indicated.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage with Lactulose Genericon is defined in regulatory documents by acute gastrointestinal presentations resulting from an exaggerated osmotic effect. The documented clinical manifestations are primarily diarrhea and abdominal cramps; nausea and vomiting may also occur.

The principal severe consequence of overdosage is the potential for critical fluid and electrolyte imbalance. Excessive loss of fluids through diarrhea can lead to serious laboratory abnormalities such as Hypokalemia (low potassium) and Hypernatremia (high sodium).

The official guidance mandates immediate action: the medication must be terminated promptly. Urgent medical attention is required if an unusual diarrheal condition or any sign of severe fluid depletion or electrolyte imbalance manifests. In such cases, management is supportive and symptomatic, with professional intervention focusing on the replacement of lost fluids and electrolytes. Regulatory documents note that elderly or debilitated patients are particularly vulnerable to these electrolyte disturbances and require close monitoring. No specific pharmacological antidote is listed in the official prescribing information; treatment relies on stabilizing the patient and correcting metabolic consequences.

Therapeutic Uses of Lactulose Genericon

Main Uses and Benefits of Lactulose Genericon

Lactulose Genericon is a medicinal product primarily used to manage specific digestive and metabolic conditions. It belongs to a class of medications known as osmotic laxatives and ammonia-lowering agents.

Treatment of Constipation

The primary use of Lactulose Genericon is for the symptomatic treatment of constipation. It works by drawing water into the bowel, which softens the stool and increases its volume. This process stimulates bowel movements and facilitates easier evacuation. It is used in cases where soft stools are medically desirable, such as for individuals with hemorrhoids or those recovering from surgery involving the lower digestive tract.

Management of Portal Systemic Encephalopathy

Lactulose Genericon is also indicated for the prevention and treatment of portal systemic encephalopathy (PSE). This is a complex neurological condition that can occur as a complication of advanced liver disease.

In this context, the medication helps reduce the levels of ammonia in the bloodstream. It achieves this by:

  • Shifting the pH balance in the colon to make it more acidic.
  • Converting ammonia into ammonium, which is more difficult for the body to absorb.
  • Promoting the migration of ammonia from the blood into the colon so it can be excreted from the body.

Benefits for Digestive Health

By acting as a prebiotic-like substance, lactulose supports the growth of beneficial acid-loving bacteria, such as Lactobacillus and Bifidobacterium, while inhibiting the growth of potentially harmful bacteria. This helps maintain a more balanced intestinal environment during the treatment process.

Eligibility and Restrictions for Use

Who Can and Cannot Use Lactulose Genericon?

The population eligibility for using Lactulose Genericon is strictly defined by regulatory documents, focusing on patient health status and age.


Contraindicated Populations (Must Not Use)

The medicine is contraindicated and must not be used by patients diagnosed with Galactosaemia or those requiring a low galactose diet due to the drug’s composition. It is also prohibited for individuals with Gastrointestinal Obstruction, conditions risking Digestive Perforation, or active Acute Inflammatory Bowel Disease.

Age-Based and Conditional Eligibility

Population Regulatory Status
Adults and Adolescents Approved for standard use.
Children and Infants Use should be exceptional and administered only under medical supervision.
Pregnant or Lactating Use may be considered if necessary; no effects are generally anticipated on the infant or fetus.
Diabetics Caution is advised when prescribing the high doses required for treating Hepatic Encephalopathy.

Special Note: Patients with hepatic or renal impairment do not typically require a dosage adjustment for constipation treatment. If use extends beyond six months, regulators advise that periodic control of electrolytes is indicated for certain patients, including older adults.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Lactulose is minimally absorbed from the gastrointestinal tract, but its effects in the colon can interact with other medicines in two main ways: electrolyte balance and colonic pH changes.

Potential Drug-Drug Interactions

Interacting Product Category Mechanism and Clinical Effect
Potassium-Losing Diuretics (e.g., thiazides, loop diuretics like furosemide) and Corticosteroids (steroids) Chronic or excessive use of Lactulose may cause diarrhea and hypokalaemia (low potassium). This effect is additive with other potassium-losing drugs, increasing the risk of severe electrolyte imbalance.
Cardiac Glycosides (e.g., digoxin) Hypokalaemia caused by Lactulose-induced diarrhea can increase the toxicity and effect of cardiac glycosides on the heart.
Oral Anti-infective Agents (e.g., neomycin) These may interfere with the colonic bacteria needed to break down lactulose. This interference can reduce the essential acidification of the colonic contents, potentially lowering the desired therapeutic effect.
pH-Dependent Released Drugs (e.g., 5-ASA products like mesalazine) Lactulose's effect of lowering the colonic pH may lead to the inactivation or reduced release of medicines whose function relies on a higher pH in the colon.
Other Laxatives Concomitant use with other laxatives, especially during treatment for hepatic encephalopathy, should be avoided as the resulting loose stools can hinder the correct dose titration of Lactulose.

Important Interaction Notes

Patients who are elderly, frail, or in bad general condition taking Lactulose for more than six months should have their serum electrolytes (potassium, chloride, and carbon dioxide) checked periodically to monitor for potential drug interaction-related complications from electrolyte loss.

Mechanism of Action

The active molecule, lactulose, is a synthetic disaccharide that resists hydrolysis by human intestinal enzymes. As a result, it travels intact to the large intestine, where its action is initiated. The primary biological targets are the saccharolytic colonic bacteria, such as Bifidobacteria and Lactobacilli. These flora utilize the lactulose as a nutritional substrate, initiating a bioconversion process known as fermentation. This fermentation yields Short-Chain Fatty Acids (SCFAs) like lactic and acetic acids, which function as the mechanistic effectors. The accumulation of these non-absorbable SCFAs creates a significant hyperosmotic environment in the colonic lumen. This osmotic gradient physically draws water from the intestinal wall, directly causing the contents' hydration and volume to increase. Concurrently, the acidic nature of the SCFAs lowers the pH and stimulates the colon's smooth muscle activity, increasing peristaltic contractions. This combined physiological consequence of increased water retention and enhanced transit represents the drug's localized mechanism.

Dosage and Administration Information

How to Use Lactulose Genericon

Lactulose Genericon is an oral solution and must be administered strictly via the oral route. The medication is available in a standard concentration of 10 g of lactulose per 15 mL of solution. It is important to note that the therapeutic effect may require 24 to 48 hours to manifest.

Official Dosing and Administration

Doses should be measured using a calibrated device provided with the medicine. To improve acceptability, the solution may be taken undiluted or mixed with water, milk, or fruit juice. Sufficient fluid intake (1.5 to 2 L daily) is recommended during therapy to support the medication's osmotic action.

Indication Starting Dose (Adults) Maintenance Dose (Adults) Notes on Frequency and Titration
Chronic Constipation 15 to 45 mL (10 to 30 g) daily. 15 to 30 mL (10 to 20 g) daily. May be taken as a single daily dose or in two divided doses.
Hepatic Encephalopathy (HE) 30 to 50 mL three to four times daily. Adjusted to produce 2 to 3 soft stools per day. Dose is adjusted (titrated) according to patient response; a rapid laxation regimen may be used initially.

Special Population Rules

No special dosage recommendations exist for older adults or patients with renal or hepatic impairment due to the drug's negligible systemic absorption. Use in children should be under medical supervision, with specific dose ranges outlined in product information for pediatric age groups.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lactulose Genericon

Evidence for Use in Chronic Constipation

This section will summarize the structure of clinical research for constipation, including the types of randomized controlled trials (RCTs) conducted, the specific symptoms and outcomes measured, and how lactulose was studied compared to placebo and other laxatives.

Chronic constipation has been a primary focus of research for lactulose, with numerous studies, primarily short-term randomized controlled trials (RCTs). The studies generally focused on adults who met standard diagnostic criteria for chronic or functional constipation. Research has also been conducted to evaluate lactulose in special populations, including studies exploring outcomes related to the symptoms experienced by children with functional constipation.

In these research scenarios, studies monitored changes related to physical discomfort. Research examined symptom intensity or variability by monitoring outcomes related to bowel movement frequency (such as the number of spontaneous movements per week) and stool characteristics (often measured using the Bristol Stool Scale). Studies observed and reported patterns related to changes in both the frequency and consistency of bowel movements during the study period. Studies also explored outcomes reflecting daily functioning by assessing patient-reported outcomes describing perceived discomfort, such as straining and abdominal discomfort.

Key Study Outcomes and Measurements

This sub-section will detail the primary endpoints researchers used in the trials, such as measurements of bowel movement frequency, shifts in stool consistency (e.g., Bristol Stool Scale scores), and patient-reported measures of associated discomfort.

Evidence for Use in Hepatic Encephalopathy

This section will outline the evidence base supporting the use of lactulose for liver-related complications, including the types of RCTs used for treating acute episodes and for preventing future occurrences (prophylaxis), and the specific populations of patients with cirrhosis who were studied.

Lactulose was studied for the management of hepatic encephalopathy (HE), which involves periods of heightened symptoms associated with acute or disruptive episodes linked to liver disease. The evidence base includes RCTs and subsequent meta-analyses. The core outcomes monitored included the resolution of neurological symptoms (assessed via clinical grading scales) and shifts in physiological biomarkers, such as blood ammonia levels. The findings indicate that lactulose was associated with patterns related to change in clinical grading scores and ammonia levels during the acute phase of treatment.

What is Still Uncertain About Lactulose Genericon

The broader evidence landscape contributes to understanding symptom patterns, but several areas of uncertainty remain. Evidence quality varies across studies, particularly among older RCTs for hepatic encephalopathy, where sample sizes were modest and certain methodological standards were not consistently met. Findings were mixed in some comparative studies that evaluated lactulose against newer agents like PEG for chronic constipation, leading to ongoing scientific discourse. Additionally, there is limited information for long-term outcomes for constipation, meaning that certainty remains low regarding effects tracked over many months or years.

Key Studies & References Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by AASLD and EASL

Frequently Asked Questions (FAQ)

Common questions about Lactulose Genericon (FAQ)


Q: Is Lactulose Genericon safe to use for a long time?

Regulatory guidance addresses chronic use of the medicine. If treatment extends for more than six months, official documents recommend periodic control of serum electrolytes (such as potassium). This monitoring is indicated particularly for elderly patients or those whose general condition is poor.

Q: Is it normal to experience gas and bloating after starting Lactulose Genericon?

Yes, flatulence (gas) is listed as a common side effect in official product information. This effect is generally observed during the first few days of treatment. As the body adjusts to the medication, official documents indicate that this discomfort typically disappears. Bloating is often associated with the documented effect of gas.

Q: Can Lactulose Genericon be taken with common pain relievers like paracetamol?

Official drug interaction lists focus on medicines that may affect the body’s potassium levels or interfere with colonic pH. Paracetamol (acetaminophen) is not specifically listed as a known interacting medicine in regulatory documents, meaning no specific warning against co-administration is generally provided in official documents.

Q: Is Lactulose Genericon appropriate for use during pregnancy according to regulatory bodies?

According to regulatory documents, the use of Lactulose Genericon during pregnancy may be considered if necessary. This is due to the drug’s minimal systemic absorption, which leads to the anticipation of no effects on the fetus or infant. Official documents also note the drug has been assigned to Pregnancy Category B by the FDA.

Q: Does Lactulose Genericon contain any sugar or carbohydrates?

Lactulose itself is a synthetic disaccharide, a type of sugar. The final solution contains small residual amounts of the simple sugars used in its production, such as galactose, lactose, and fructose. Due to this composition, the medicine is contraindicated (must not be used) in patients diagnosed with Galactosaemia or those requiring a low galactose diet.

Q: Is there a taste or flavor to Lactulose Genericon solution?

Lactulose solution is typically described as an oral solution or syrup. Regulatory documentation notes the solution can be mixed with a liquid, such as water, milk, or fruit juice, which can be done to improve acceptability.

Q: Is Lactulose Genericon processed by the liver or kidneys?

The drug is poorly absorbed from the gastrointestinal tract and reaches the colon virtually unchanged. As it is poorly absorbed, the drug is not significantly processed by the liver. The small, negligible amount that does enter the body is generally excreted rapidly via the kidneys.

Q: What official information exists about Lactulose Genericon and driving/operating machinery?

Official product information states that this medicine has no or negligible influence on a person’s ability to drive safely or use machines. The negligible systemic absorption of the drug is the primary reason for this statement.

Q: Is Lactulose Genericon known to cause allergic reactions?

Official safety documents list hypersensitivity reactions as a possible adverse reaction. This includes signs like rash, itching (pruritus), and hives (urticaria). It is noted in regulatory information that the official frequency of these allergic reactions is described as 'not known'.

Q: Why do some people experience initial nausea when using Lactulose Genericon?

Nausea (feeling sick to your stomach) is listed as a common side effect in official documents. While the specific reason for initial nausea is not detailed, this reaction is listed as a common effect associated with the drug’s localized action in the gastrointestinal tract.

Q: What is the general duration of effect after Lactulose Genericon is taken?

The drug’s action is localized to the colon because it is poorly absorbed and reaches the lower intestine intact. Any unabsorbed medicine is largely excreted in the stool. The small amount that is absorbed into the body is generally excreted in the urine within approximately 24 hours.

Q: Are there restrictions on using Lactulose Genericon with certain types of foods?

There are generally no specific restrictions on food types with Lactulose Genericon. Official guidance permits mixing the solution with various liquids, including milk and fruit juice. The main restriction is a contraindication for patients who must follow a low galactose diet due to the presence of residual sugars.

Q: Can Lactulose Genericon be used to help with preparation for a medical procedure?

The primary approved indications are chronic constipation and hepatic encephalopathy. However, the medication's bowel evacuation effect has been referenced in clinical literature related to certain medical procedures, which is noted in regulatory contexts.

Q: Are changes in stool consistency expected when using Lactulose Genericon?

Yes, changes in stool consistency are an expected part of the drug’s function. The medicine works by drawing water into the colon, which causes the stools to become softer and increase in volume. This action is intended to normalize the consistency of the stools to relieve constipation.

Q: Is Lactulose Genericon known to cause mineral deficiencies?

The primary safety concern involving electrolyte levels is the risk of imbalance, such as low potassium (hypokalemia). This risk is associated with the long-term use of high doses that may lead to diarrhea and subsequent electrolyte loss. General mineral deficiencies are not explicitly listed as a commonly expected adverse effect in official documents.

Q: What distinguishes Lactulose Genericon from other forms of lactulose on the market?

Lactulose Genericon is a brand-specific preparation that contains the active ingredient lactulose at the standard concentration. While the core ingredient is the same as in other brands, the specific manufacturer (Genericon Pharma), formulation, and associated regulatory labeling are distinct to this product.

How should Lactulose Genericon be stored and disposed of?

Storage and Disposal Requirements

Lactulose oral solution must be stored according to official regulatory labeling to ensure its stability and safety.

Storage Conditions

Requirement Specific Instruction
Temperature Store below 25 °C (room temperature).
Prohibited Environment Do not freeze the solution.
Container Integrity Keep the container tightly closed.
Child Safety Store out of the sight and reach of children.

Stability and Disposal

The solution has an in-use stability limit and specific disposal rules. Once the bottle is opened, the solution must be used within 12 months. Under storage, a normal darkening of color may occur but does not affect the drug's action; however, discard it if it becomes very dark and cloudy. Unused medicine must not be thrown away via wastewater or household waste but should be disposed of in accordance with local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lactulose Genericon found in:

A-Z Index: